Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688393's Days Payable is ranked better than 62.09% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.85
vs SHSE:688393: 92.81
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou LBP Medicine Science & Technology Co Days Payable Chart
Guangzhou LBP Medicine Science & Technology Co Annual Data
SHSE:688393 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Guangzhou LBP Medicine Science & Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangzhou LBP Medicine Science & Technology Co Days Payable vs Medical Devices & Instruments Industry
Guangzhou LBP Medicine Science & Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) has a Days Payable of 107.44 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangzhou LBP Medicine Science & Technology Co and its competitors. This is 20% below median its historical median of 134.57. Over the past decade, Guangzhou LBP Medicine Science & Technology Co's Days Payable has ranged from 81.23 to 208.73. According to the industry distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #301 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 37.9%.
Is Guangzhou LBP Medicine Science & Technology Co's Days Payable too high?
Guangzhou LBP Medicine Science & Technology Co's current Days Payable of 107.44 is 20% below median its 10-year median of 134.57. Over the past 10 years, this metric has ranged from a low of 81.23 to a high of 208.73. The Medical Devices & Instruments industry median Days Payable is 67.85. Guangzhou LBP Medicine Science & Technology Co's value of 107.44 is 58.3% above this industry median. Based on the distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #301 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Guangzhou LBP Medicine Science & Technology Co has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou LBP Medicine Science & Technology Co's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Guangzhou LBP Medicine Science & Technology Co ranks #301 out of 794 companies for Days Payable. This puts Guangzhou LBP Medicine Science & Technology Co in the upper half of its industry. The industry median Days Payable is 67.85. Guangzhou LBP Medicine Science & Technology Co's value of 107.44 is 58.3% above this benchmark. Historically, Guangzhou LBP Medicine Science & Technology Co's own Days Payable has ranged from 81.23 to 208.73 over the past decade. While the company's 10-year median is 134.57 vs. the industry median of 67.85, Guangzhou LBP Medicine Science & Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.85, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangzhou LBP Medicine Science & Technology Co's current Days Payable of 107.44 is 58.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangzhou LBP Medicine Science & Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangzhou LBP Medicine Science & Technology Co's current Days Payable is 107.44, which is 20% below median its own 10-year median of 134.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou LBP Medicine Science & Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥25.52, compared to a current price of ¥17.17 — trading 32.7% below its estimated fair value. The current Days Payable is 107.44, which is 20% below median its 10-year median of 134.57 and 58.3% above the Medical Devices & Instruments industry median of 67.85. Guangzhou LBP Medicine Science & Technology Co's overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guangzhou LBP Medicine Science & Technology Co (SHSE:688393), the current Days Payable is 107.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangzhou LBP Medicine Science & Technology Co (SHSE:688393) Overvalued in 2026?
Based on GuruFocus' analysis, Guangzhou LBP Medicine Science & Technology Co stock appears to be undervalued.
The current stock price of ¥17.17 is trading 32.7% below its estimated GF Value™ of ¥25.52.
GuruFocus considers Guangzhou LBP Medicine Science & Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688393:
Days Payable: 107.44 (20% below median its 10-year median of 134.57)
GF Value™: ¥25.52 vs. price of ¥17.17 (32.7% below fair value)
Industry Position: 58.3% above the Medical Devices & Instruments median (#301 of 794)
No single metric tells the full story. See the SHSE:688393 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangzhou LBP Medicine Science & Technology Co Business Description
Guangzhou LBP Medicine Science & Technology Co Ltd is engaged in production and sales of in vitro diagnostic reagents and instruments. The company's products include Fluorescence in situ hybridization (FISH) series; Immunohistochemistry (IHC) series; Liquid - based cytology (LBP) series; PCR series; and medical laboratory.
62GF Score
Get the complete analysis for SHSE:688393
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688393 has been successfully added to your 
